USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
21-May-2026
Global
Market Research
PLOQ-01-00-00-00
HC_2026_34604
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow systems are emerging as key competitive differentiators by enabling large-scale genomic interpretation and improving accessibility of advanced diagnostics in routine care. The convergence of dPCR, NGS, CRISPR-Cas, and nanotechnology is creating multi-platform molecular testing ecosystems with improved speed, accuracy, and scalability across oncology, infectious diseases, and precision medicine. NGS continues to drive adoption through rapid, cost-effective multi-gene analysis for oncology, rare diseases, and reproductive health, with companies such as MGI Tech expanding access through automated sequencing solutions. The sector is also witnessing increased mergers and acquisitions aimed at portfolio expansion, R&D enhancement, and commercialization acceleration. Simultaneously, AI is evolving into a laboratory co-pilot, improving operational efficiency and diagnostic accuracy through integration with LIMS and human-in-the-loop clinical validation frameworks. Companion diagnostics are becoming central to precision medicine, with collaborations between Thermo Fisher and Pfizer, Guardant Health and Pfizer, and Illumina with pharmaceutical companies enabling targeted therapies supported by validated molecular testing.
Author: Chandni Hussain
Scope of Analysis
Global Molecular Diagnostics Application Segmentation
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Industrial Engineering Industry
Growth Metrics
Growth Drivers
Growth Driver Analysis
Growth Restraints
Growth Restraint Analysis
Growth Drivers Accelerating Molecular Diagnostics Market Expansion
Four Structural Shifts Redefining MDx
The Molecular Diagnostics Technology Convergence Matrix
Market Trend 1: Rising Demand for Rapid Diagnostics Accelerates Growth in the Molecular Diagnostics Industry
Market Trend 2: NGS Adoption Expanding Market Leadership in Personalized Medicine
Market Trend 3: M&A Momentum Reshaping Competitive Dynamics in the Molecular Diagnostics Industry
Market Trend 4: Emerging Technologies Driving Competitive Differentiation in Molecular Diagnostics
The Al Co-Pilot: Workflow Automation to Diagnostic Precision
The Digital Backbone Powering Scalable Molecular Diagnostics
Molecular Diagnostics and Pharma Interlock Through Companion Diagnostics
The Companion Diagnostics (CDx) Flywheel
Consolidating the Precision Molecular Oncology Care Continuum
Global Molecular Diagnostics Competitive Landscape
Competitive Landscape: Emerging Players
Competitive Landscape of Molecular Diagnostics: Race Toward Early Detection and AI-Led Platforms
Unlocking Value Through Diagnostics–Pharma Synergies
Broader Infrastructure Moves Support the Core Molecular Trends
The Regulatory Reality: A Harmonization Roadmap
Changing Regulatory Dynamics in the Molecular Diagnostics Market
Growth Opportunity 1: AI-Integrated Molecular Diagnostics Platforms Accelerate Precision Medicine and Clinical Decision Support
Growth Opportunity 2: Multiomics Liquid Biopsy Platforms Expand Early Cancer Detection and Minimal Residual Disease Monitoring
Growth Opportunity 3: Expansion of NGS Enabling Comprehensive Genomic Profiling
Growth Opportunity 4: Pharmacogenomics-Driven Molecular Testing Enhances Personalized Drug Selection and Treatment Outcomes
Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
Speak directly with our analytics experts for tailored recommendations.
Recent related In Vitro Diagnostics (IVD) research
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
25 Aug 2026 | Global | Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.
The study assesses key technology shifts, including rapid molecular t...
21 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...
07 Aug 2026 | Global | Customer Research
Laboratory Product Purchasing Trends, United States and Europe, 2025–2026
Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The su...
21 Jul 2026 | Global | Market Research
Point-of-Care Testing Market, Global, 2024–2031
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Author: Chandni Hussain
| Deliverable Type | Market Research |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Molecular diagnostic market |
| Keyword 2 | Next-Generation Sequencing (NGS) |
| Keyword 3 | Precision medicine diagnostics |
| Podcast | No |
| Predecessor | None |
| WIP Number | PLOQ-01-00-00-00 |